Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Phase 3 Trials #Cancer #Novo Nordisk

Tag: Cobra Venom

Biotechnology News Toxicology

CRISPR technology paves the way for a new antidote for Cobra bites

  • By Editor's Desk
  • 19 July 2024
Cobra Snake Image

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Tagged Cobra Venom, CRISPR
Toxicology

Cobra’s Neurotoxic Venom | Details – Types, Effects, and Pharmacology

  • By Achuth B S
  • 15 September 2023
Cobra Snake Image

Elapidae is a family of poisonous snakes that includes the cobras. They are recognized for their unusual looks, deadly venom, and the capacity to lift the front portion of their bodies when attacked, generating a distinctive hood shape.

Tagged Cobra Snake, Cobra Venom
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Amgen and AstraZeneca Report TEZSPIRE Eosinophilic Esophagitis Phase 3 CROSSING Results
Clinical Data Healthcare & Pharmaceuticals News

Amgen and AstraZeneca Report TEZSPIRE Eosinophilic Esophagitis Phase 3 CROSSING Results

20 October 202620 October 2026
Clinical Trials & Data Desk
Merck KGaA Announces Silence Therapeutics Acquisition to Add Divesiran siRNA Therapy to Rare Disease Pipeline
Business Healthcare & Pharmaceuticals Merger & Acquisitions News

Merck KGaA Announces Silence Therapeutics Acquisition to Add Divesiran siRNA Therapy to Rare Disease Pipeline

19 October 202620 October 2026
BiotechReality Business Intelligence Desk
MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan
Clinical Data Healthcare & Pharmaceuticals News Oncology

MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan

17 October 202617 October 2026
Clinical Trials & Data Desk
Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types
Regulatory Approval Healthcare & Pharmaceuticals News Oncology

Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types

16 October 202617 October 2026
Clinical Trials & Data Desk
Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year
Clinical Data Healthcare & Pharmaceuticals News

Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year

15 October 202615 October 2026
Clinical Trials & Data Desk
Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing
Business Clinical Data Gene Therapy Healthcare & Pharmaceuticals News

Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing

14 October 202614 October 2026
BiotechReality Business Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026
  • Commercial Product Manager – Centrifuge – ThermoFisher, Singapore & Malaysia
    7 October 2026
  • Regulatory Affairs Specialist – Lonza, Hyderabad
    4 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter